Literature DB >> 30719630

Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension.

Arthur P DeMarzo1.   

Abstract

In November 2017, the American College of Cardiology and American Heart Association released new guidelines on hypertension that lowered the blood pressure (BP) definition of stage 1. Impedance cardiography (ICG) has shown that ventricular, vascular, and hemodynamic abnormalities are prevalent in adults over 40 years of age with at least 2 cardiovascular (CV) risk factors. This suggests that all stage 1 hypertension patients with multiple CV risk factors, over 40 years of age, have earlystage CV disease and should be treated. For many of these patients, ICG testing has shown low cardiac index with high systemic vascular resistance or vice versa. If only BP is measured, these significant extremes in hemodynamics would be unknown. With ICG data, drug selection and titration can be customized based on the abnormal underlying mechanisms to rapidly control BP while reducing adverse side effects and preventing progression of CV disease.

Entities:  

Keywords:  Cardiovascular disease; Hemodynamics; Hypertension; Impedance cardiography; Prevention; Risk factors

Mesh:

Substances:

Year:  2019        PMID: 30719630     DOI: 10.1007/s40292-019-00304-w

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  18 in total

1.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Using impedance cardiography to detect subclinical cardiovascular disease in women with multiple risk factors: a pilot study.

Authors:  Arthur P Demarzo
Journal:  Prev Cardiol       Date:  2009

3.  A new approach for low-cost noninvasive detection of asymptomatic heart disease at rest.

Authors:  Arthur P DeMarzo; James E Calvin
Journal:  Prev Cardiol       Date:  2007

4.  Using impedance cardiography to assess left ventricular systolic function via postural change in patients with heart failure.

Authors:  Arthur P DeMarzo; James E Calvin; Russell F Kelly; Thomas D Stamos
Journal:  Prog Cardiovasc Nurs       Date:  2005

5.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.

Authors:  R S Vasan; M G Larson; E P Leip; W B Kannel; D Levy
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

6.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

7.  Using impedance cardiography with postural change to stratify patients with hypertension.

Authors:  Arthur P DeMarzo
Journal:  Ther Adv Cardiovasc Dis       Date:  2011-04-28

8.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Authors:  Giuseppe Mancia; Stéphane Laurent; Enrico Agabiti-Rosei; Ettore Ambrosioni; Michel Burnier; Mark J Caulfield; Renata Cifkova; Denis Clément; Antonio Coca; Anna Dominiczak; Serap Erdine; Robert Fagard; Csaba Farsang; Guido Grassi; Hermann Haller; Anthony Heagerty; Sverre E Kjeldsen; Wolfgang Kiowski; Jean Michel Mallion; Athanasios Manolis; Krzysztof Narkiewicz; Peter Nilsson; Michael H Olsen; Karl Heinz Rahn; Josep Redon; José Rodicio; Luis Ruilope; Roland E Schmieder; Harry A J Struijker-Boudier; Pieter A van Zwieten; Margus Viigimaa; Alberto Zanchetti
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

9.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

10.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.